We are live on ! Find out more
RPCA

Running Point Capital Advisors Portfolio holdings

AUM $367M
1-Year Est. Return 12.19%
This Fund
S&P 500
This Quarter Est. Return
+5.91%
1 Year Est. Return
+12.19%
3 Year Est. Return
+52.1%
5 Year Est. Return
+37.6%
10 Year Est. Return
AUM
$163M
AUM Growth
+$11.9M
Cap. Flow
+$4.59M
Cap. Flow %
2.82%
Top 10 Hldgs %
51.37%
Holding
240
New
15
Increased
48
Reduced
45
Closed
31

Sector Composition

Rank Sector Weight
1 Technology 3.32%
2 Financials 2.41%
3 Healthcare 0.98%
4 Consumer Discretionary 0.66%
5 Consumer Staples 0.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTUM icon
151
iShares MSCI USA Momentum Factor ETF
MTUM
$25B
$80.7K 0.05%
553
ETJ
152
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$567M
$75K 0.05%
10,000
IGV icon
153
iShares Expanded Tech-Software Sector ETF
IGV
$12.7B
$73.9K 0.05%
1,445
VTV icon
154
Vanguard Morningstar Value ETF
VTV
$188B
$70.2K 0.04%
500
+400
+400% +$55.1K
WVE icon
155
Wave Life Sciences
WVE
$1.09B
$70K 0.04%
10,000
PSEC icon
156
Prospect Capital
PSEC
$1.07B
$69.9K 0.04%
10,000
JPS
157
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$68K 0.04%
10,000
XHE icon
158
State Street SPDR S&P Health Care Equipment ETF
XHE
$161M
$66.5K 0.04%
740
JQUA icon
159
JPMorgan US Quality Factor ETF
JQUA
$8.21B
$53.6K 0.03%
+1,383
New +$53.1K
IVLU icon
160
iShares MSCI Intl Value Factor ETF
IVLU
$4.42B
$52.7K 0.03%
2,276
BGY icon
161
BlackRock Enhanced International Dividend Trust
BGY
$524M
$50.2K 0.03%
10,000
VTI icon
162
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$43.3K 0.03%
226
PBYI icon
163
Puma Biotechnology
PBYI
$404M
$42.3K 0.03%
10,000
STIP icon
164
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
$41.8K 0.03%
431
+103
+31% +$10K
QUAD icon
165
Quad
QUAD
$536M
$40.8K 0.03%
10,000
SUSA icon
166
iShares ESG Optimized MSCI USA ETF
SUSA
$4.01B
$40.7K 0.03%
+495
New +$40.8K
PBI icon
167
Pitney Bowes
PBI
$2.4B
$38K 0.02%
10,000
-10,000
-50% -$33.7K
GDX icon
168
VanEck Gold Miners ETF
GDX
$22.7B
$34.6K 0.02%
1,206
GRTS
169
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$34.5K 0.02%
10,000
KPTI icon
170
Karyopharm Therapeutics
KPTI
$43.5M
$34K 0.02%
667
NCV
171
Virtus Convertible & Income Fund
NCV
$378M
$34K 0.02%
2,500
VCLT icon
172
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.81B
$34K 0.02%
449
+123
+38% +$9.25K
ATRA icon
173
Atara Biotherapeutics
ATRA
$75.5M
$32.8K 0.02%
400
IDEV icon
174
iShares Core MSCI International Developed Markets ETF
IDEV
$31.7B
$32.5K 0.02%
580
-280
-33% -$15K
EMBD icon
175
Global X Emerging Markets Bond ETF
EMBD
$249M
$32.4K 0.02%
+1,515
New +$31.6K

Similar funds

Running Point Capital Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Running Point Capital Advisors held 240 positions worth $163M, up 7.9% from $151M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Running Point Capital Advisors's Q4 2022 filing shows 15 new, 48 increased, 45 reduced and 31 closed positions. Its largest new stake was First Trust Managed Municipal ETF: 10,692 shares worth $536K. The largest sale was Meta Platforms (Facebook), an estimated $1.48M.

By sector, the portfolio is most concentrated in Technology at 3.3% of assets, down from 3.4% a quarter earlier, followed by Financials and Healthcare.

  • Running Point Capital Advisors's largest Q4 2022 buy was First Trust Managed Municipal ETF: 10,692 shares worth $536K.
  • Running Point Capital Advisors added most to Invesco NASDAQ 100 ETF in Q4 2022, an estimated $1.55M increase.
  • Running Point Capital Advisors's biggest Q4 2022 reduction was Meta Platforms (Facebook), cutting an estimated $1.48M.
  • Running Point Capital Advisors fully exited Tesla in Q4 2022, selling an estimated $234K.
  • Running Point Capital Advisors's ten largest holdings make up 51% of its $163M portfolio in Q4 2022.
  • Running Point Capital Advisors opened 15 new positions and closed 31 in Q4 2022.
  • Running Point Capital Advisors's portfolio value rose 7.9% quarter-over-quarter to $163M.

Based on Running Point Capital Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.